☰

Gail E. Sonenshein

Affiliations: 
Boston University, Boston, MA, United States 
Area:
Molecular Biology, Biochemistry
Website:
https://facultyprofiles.tufts.edu/gail-sonenshein
Google:
"Gail Sonenshein"
Bio:

https://books.google.com/books?id=ij_gAAAAMAAJ
DOI: 10.1016/0006-291X(68)90578-0

Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Charles E. Holt grad student 1970 MIT (DevTree)
 (Studies on the Satellite DNA's of Physarum Polycephalum)

Children

Sign in to add trainee
Mary A. Stepp grad student 1986 Boston University (E-Tree)
William C. Yang grad student 2000 Boston University
Kathryn T. Kavanagh grad student 2002 Boston University
Claudia S. Hofmann grad student 2003 Boston University
Elizabeth G. Demicco grad student 2005 Boston University
Shangquin Guo grad student 2005 Boston University
Vidyalakshmi Chandramohan grad student 2006 Boston University
Xiaobo Wang grad student 2007 Boston University
Nora Mineva grad student 2008 Boston University
Chengyin Min grad student 2009 Boston University
Junfeng Wu grad student 2010 Boston University
Ziyang Yu grad student 2011 Boston University

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mineva ND, Pianetti S, Das SG, et al. (2024) A Novel Class of Human ADAM8 Inhibitory Antibodies for Treatment of Triple-Negative Breast Cancer. Pharmaceutics. 16
Pianetti S, Miller KD, Chen HH, et al. (2023) ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients. Cancer Cell International. 23: 165
de la Cueva A, Emmerling M, Lim SL, et al. (2018) A Polymorphism in the Lysyl Oxidase Propeptide Domain Accelerates Carcinogen-induced Cancer. Carcinogenesis
Sánchez-Morgan N, Kirsch KH, Trackman PC, et al. (2017) UXT is a LOX-PP Interacting Protein that Modulates Estrogen Receptor Alpha Activity in Breast Cancer Cells. Journal of Cellular Biochemistry
Das SG, Pianetti S, Sonenshein GE, et al. (2017) Abstract 23: Antibody targeting of ADAM8 for treatment of triple-negative breast cancer Cancer Research. 77: 23-23
Romagnoli M, Pianetti S, Das SG, et al. (2017) Abstract 1137: ADAM8 drives aggressive phenotype of triple-negative inflammatory breast cancer & constitutes a novel therapeutic target Cancer Research. 77: 1137-1137
Lyons J, Polmear M, Mineva ND, et al. (2016) Endogenous light scattering as an optical signature of circulating tumor cell clusters. Biomedical Optics Express. 7: 1042-50
Das SG, Romagnoli M, Mineva ND, et al. (2016) miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells. Breast Cancer Research : Bcr. 18: 40
Srinivasan S, Romagnoli M, Bohm A, et al. (2014) N-glycosylation regulates ADAM8 processing and activation. The Journal of Biological Chemistry. 289: 33676-88
Romagnoli M, Mineva ND, Polmear M, et al. (2014) ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis. Embo Molecular Medicine. 6: 278-94
See more...